1,041
Views
59
CrossRef citations to date
0
Altmetric
Reviews

Novel NMDA receptor modulators: an update

, , , , , & show all
Pages 1337-1352 | Published online: 26 Sep 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Khalid A. Agha, Nader E. Abo-Dya, Abdul Rashid Issahaku, Clement Agoni, Mahmoud E. S. Soliman, Eatedal H. Abdel-Aal, Zakaria K. Abdel-Samii & Tarek S. Ibrahim. (2022) Novel Sunifiram-carbamate hybrids as potential dual acetylcholinesterase inhibitor and NMDAR co-agonist: simulation-guided analogue design and pharmacological screening. Journal of Enzyme Inhibition and Medicinal Chemistry 37:1, pages 1241-1256.
Read now
Claudia Beato, Chiara Pecchini, Chiara Cocconcelli, Barbara Campanini, Marialaura Marchetti, Marco Pieroni, Andrea Mozzarelli & Gabriele Costantino. (2016) Cyclopropane derivatives as potential human serine racemase inhibitors: unveiling novel insights into a difficult target. Journal of Enzyme Inhibition and Medicinal Chemistry 31:4, pages 645-652.
Read now
Eugene Hsu, Sunberri Murphy, David Chang & Steven P Cohen. (2015) Expert opinion on emerging drugs: chronic low back pain. Expert Opinion on Emerging Drugs 20:1, pages 103-127.
Read now
Katie L Strong, Yao Jing, Anthony R Prosser, Stephen F Traynelis & Dennis C Liotta. (2014) NMDA receptor modulators: an updated patent review (2013 – 2014). Expert Opinion on Therapeutic Patents 24:12, pages 1349-1366.
Read now
Franciszek Sączewski & Łukasz Balewski. (2013) Biological activities of guanidine compounds, 2008 – 2012 update. Expert Opinion on Therapeutic Patents 23:8, pages 965-995.
Read now

Articles from other publishers (53)

Jesse E. Hanson, Hongjie Yuan, Riley E. Perszyk, Tue G. Banke, Hao Xing, Ming-Chi Tsai, Frank S. Menniti & Stephen F. Traynelis. (2023) Therapeutic potential of N-methyl-D-aspartate receptor modulators in psychiatry. Neuropsychopharmacology 49:1, pages 51-66.
Crossref
Vinod Ugale, Rutuja Deshmukh, Deepak Lokwani, P. Narayana Reddy, Saurabh Khadse, Prashant Chaudhari & Prasad P. Kulkarni. (2023) GluN2B subunit selective N-methyl-D-aspartate receptor ligands: Democratizing recent progress to assist the development of novel neurotherapeutics. Molecular Diversity.
Crossref
Ming-Wei Li, Tze-Chen Chao, Li-Yi Lim, Hsi-Hsien Chang & Stephen Shei-Dei Yang. (2023) The Acute Effects and Mechanism of Ketamine on Nicotine-Induced Neurogenic Relaxation of the Corpus Cavernosum in Mice. International Journal of Molecular Sciences 24:8, pages 6976.
Crossref
Onur Cil, Marc O. Anderson, Livia de Souza Goncalves, Joseph-Anthony Tan, Peter M. Haggie & Alan S. Verkman. (2023) Small molecule inhibitors of intestinal epithelial anion exchanger SLC26A3 (DRA) with a luminal, extracellular site of action. European Journal of Medicinal Chemistry 249, pages 115149.
Crossref
Marlyn S. Rada, Wilson Cardona-G, Karina Sierra, Edison Osorio, Luis Alfonso Gonzalez-Molina, Rafael Posada-Duque & Andrés F. Yepes. (2022) Discovery of novel neuroprotective cinnamoyl-M30D hybrids targeting Alzheimer’s disease. Medicinal Chemistry Research 31:11, pages 1974-1989.
Crossref
Yan Li, Zhicheng Gu, Shuxian Lin, Lei Chen, Valentina Dzreyan, Moez Eid, Svetlana Demyanenko & Bin He. (2022) Histone Deacetylases as Epigenetic Targets for Treating Parkinson’s Disease. Brain Sciences 12:5, pages 672.
Crossref
Hilal Ozturk, Nuri Yorulmaz, Mustafa Durgun & Harun Basoglu. (2021) In silico investigation of Alliin as potential activator for AMPA receptor. Biomedical Physics & Engineering Express 8:1, pages 015002.
Crossref
N.V. Prasanth, P. Pandian & T. Balasubramanian. (2021) Role of NMDA Receptors in Alzheimer's Disease Pathology and Potential NMDA Receptor Blockers from Medicinal Plants - A Review. Asian Journal of Pharmaceutical Research and Health Care 13:4, pages 321.
Crossref
Serena Boccella, Francesca Guida, Monica Iannotta, Fabio Arturo Iannotti, Rosmara Infantino, Flavia Ricciardi, Claudia Cristiano, Rosa Maria Vitale, Pietro Amodeo, Ida Marabese, Carmela Belardo, Vito de Novellis, Salvatore Paino, Enza Palazzo, Antonio Calignano, Vincenzo Di Marzo, Sabatino Maione & Livio Luongo. (2021) 2-Pentadecyl-2-oxazoline ameliorates memory impairment and depression-like behaviour in neuropathic mice: possible role of adrenergic alpha2- and H3 histamine autoreceptors. Molecular Brain 14:1.
Crossref
Kasper B. Hansen, Lonnie P. Wollmuth, Derek Bowie, Hiro Furukawa, Frank S. Menniti, Alexander I. Sobolevsky, Geoffrey T. Swanson, Sharon A. Swanger, Ingo H. Greger, Terunaga Nakagawa, Chris J. McBain, Vasanthi Jayaraman, Chian-Ming Low, Mark L. Dell’Acqua, Jeffrey S. Diamond, Chad R. Camp, Riley E. Perszyk, Hongjie Yuan & Stephen F. Traynelis. (2022) Structure, Function, and Pharmacology of Glutamate Receptor Ion Channels. Pharmacological Reviews 73:4, pages 1469-1658.
Crossref
Kai Zhang, Shiou Zhu, Jiamei Li, Tingting Jiang, Lu Feng, Junping Pei, Guan Wang, Liang Ouyang & Bo Liu. (2021) Targeting autophagy using small-molecule compounds to improve potential therapy of Parkinson's disease. Acta Pharmaceutica Sinica B 11:10, pages 3015-3034.
Crossref
Katie L. Strong, Matthew P. Epplin, Kevin K. Ogden, Pieter B. Burger, Thomas M. Kaiser, Timothy J. Wilding, Hiro Kusumoto, Chad R. Camp, Gil Shaulsky, Subhrajit Bhattacharya, Riley E. Perszyk, David S. Menaldino, Miranda J. McDaniel, Jing Zhang, Phuong Le, Tue G. Banke, Kasper B. Hansen, James E. Huettner, Dennis C. Liotta & Stephen F. Traynelis. (2020) Distinct GluN1 and GluN2 Structural Determinants for Subunit-Selective Positive Allosteric Modulation of N -Methyl- d -aspartate Receptors . ACS Chemical Neuroscience 12:1, pages 79-98.
Crossref
Yong-Hyun Ko, Seon-Kyung Kim, Seok-Yong Lee & Choon-Gon Jang. (2020) Flavonoids as therapeutic candidates for emotional disorders such as anxiety and depression. Archives of Pharmacal Research 43:11, pages 1128-1143.
Crossref
Zongjian Zhu, Feng Yi, Matthew P. Epplin, Ding Liu, Samantha L. Summer, Ruth Mizu, Gil Shaulsky, Wenshu XiangWei, Weiting Tang, Pieter B. Burger, David S. Menaldino, Scott J. Myers, Dennis C. Liotta, Kasper B. Hansen, Hongjie Yuan & Stephen F. Traynelis. (2020) Negative allosteric modulation of GluN1/GluN3 NMDA receptors. Neuropharmacology 176, pages 108117.
Crossref
Matthew P. Epplin, Ayush Mohan, Lynnea D. Harris, Zongjian Zhu, Katie L. Strong, John Bacsa, Phuong Le, David S. Menaldino, Stephen F. Traynelis & Dennis C. Liotta. (2020) Discovery of Dihydropyrrolo[1,2- a ]pyrazin-3(4 H )-one-Based Second-Generation GluN2C- and GluN2D-Selective Positive Allosteric Modulators (PAMs) of the N -Methyl- d -Aspartate (NMDA) Receptor . Journal of Medicinal Chemistry 63:14, pages 7569-7600.
Crossref
Hualong Fu, Weiting Tang, Zhen Chen, Vasily V. Belov, Genwei Zhang, Tuo Shao, Xiaofei Zhang, Qingzhen Yu, Jian Rong, Xiaoyun Deng, Wei Han, Scott J. Myers, Pilar Giffenig, Lu Wang, Lee Josephson, Yihan Shao, April T. Davenport, James B. Daunais, Mikhail Papisov, Hongjie Yuan, Zijing Li, Stephen F. Traynelis & Steven H. Liang. (2019) Synthesis and Preliminary Evaluations of a Triazole-Cored Antagonist as a PET Imaging Probe ([ 18 F]N2B-0518) for GluN2B Subunit in the Brain . ACS Chemical Neuroscience 10:5, pages 2263-2275.
Crossref
Serena Boccella, Ida Marabese, Monica Iannotta, Carmela Belardo, Volker Neugebauer, Mariacristina Mazzitelli, Gorizio Pieretti, Sabatino Maione & Enza Palazzo. (2019) Metabotropic Glutamate Receptor 5 and 8 Modulate the Ameliorative Effect of Ultramicronized Palmitoylethanolamide on Cognitive Decline Associated with Neuropathic Pain. International Journal of Molecular Sciences 20:7, pages 1757.
Crossref
Jonathan J. Waataja, Cristina D. Peterson, Harsha Verma, Cory J. Goracke-Postle, Philippe Séguéla, Eric Delpire, George L. Wilcox & Carolyn A. Fairbanks. (2019) Agmatine preferentially antagonizes GluN2B-containing N -methyl- d -aspartate receptors in spinal cord . Journal of Neurophysiology 121:2, pages 662-671.
Crossref
Vlad Bacauanu, Sébastien Cardinal, Motoshi Yamauchi, Masaru Kondo, David F. Fernández, Richard Remy & David W. C. MacMillan. (2018) Metallaphotoredox Difluoromethylation of Aryl Bromides. Angewandte Chemie International Edition 57:38, pages 12543-12548.
Crossref
Vlad Bacauanu, Sébastien Cardinal, Motoshi Yamauchi, Masaru Kondo, David F. Fernández, Richard Remy & David W. C. MacMillan. (2018) Metallaphotoredox Difluoromethylation of Aryl Bromides. Angewandte Chemie 130:38, pages 12723-12728.
Crossref
Riley Perszyk, Brooke M Katzman, Hirofumi Kusumoto, Steven A Kell, Matthew P Epplin, Yesim A Tahirovic, Rhonda L Moore, David Menaldino, Pieter Burger, Dennis C Liotta & Stephen F Traynelis. (2018) An NMDAR positive and negative allosteric modulator series share a binding site and are interconverted by methyl groups. eLife 7.
Crossref
Sharon A. Swanger, Katie M. Vance, Timothy M. Acker, Sommer S. Zimmerman, John O. DiRaddo, Scott J. Myers, Christoffer Bundgaard, Cara A. Mosley, Samantha L. Summer, David S. Menaldino, Henrik S. Jensen, Dennis C. Liotta & Stephen F. Traynelis. (2017) A Novel Negative Allosteric Modulator Selective for GluN2C/2D-Containing NMDA Receptors Inhibits Synaptic Transmission in Hippocampal Interneurons. ACS Chemical Neuroscience 9:2, pages 306-319.
Crossref
Katie L. Strong, Matthew P. Epplin, John Bacsa, Christopher J. Butch, Pieter B. Burger, David S. Menaldino, Stephen F. Traynelis & Dennis C. Liotta. (2017) The Structure–Activity Relationship of a Tetrahydroisoquinoline Class of N -Methyl- d -Aspartate Receptor Modulators that Potentiates GluN2B-Containing N -Methyl- d -Aspartate Receptors . Journal of Medicinal Chemistry 60:13, pages 5556-5585.
Crossref
Margarida Espadinha, Jorge Dourado, Rocio Lajarin-Cuesta, Clara Herrera-Arozamena, Lidia M. D. Gonçalves, María Isabel Rodríguez-Franco, Cristobal de los Rios & Maria M. M. Santos. (2017) Optimization of Bicyclic Lactam Derivatives as NMDA Receptor Antagonists. ChemMedChem 12:7, pages 537-545.
Crossref
D. S. Karlov, E. V. Radchenko, V. A. Palyulin & N. S. Zefirov. (2017) Molecular design of proneurogenic and neuroprotective compounds—allosteric NMDA receptor modulators. Doklady Biochemistry and Biophysics 473:1, pages 132-136.
Crossref
Minela Hadzic, Alexander Jack & Petra Wahle. (2017) Ionotropic glutamate receptors: Which ones, when, and where in the mammalian neocortex. Journal of Comparative Neurology 525:4, pages 976-1033.
Crossref
A. E. Karateev, D. E. Karateev & O. S. Davydov. (2017) PAIN AND INFLAMMATION. PART 1. PATHOGENETIC ASPECTS. Rheumatology Science and Practice 54:6, pages 693-704.
Crossref
Max K. Leong, Ren-Guei Syu, Yi-Lung Ding & Ching-Feng Weng. (2017) Prediction of N-Methyl-D-Aspartate Receptor GluN1-Ligand Binding Affinity by a Novel SVM-Pose/SVM-Score Combinatorial Ensemble Docking Scheme. Scientific Reports 7:1.
Crossref
C. Taghibiglou & S. Khalaj. 2017. Drug Discovery Approaches for the Treatment of Neurodegenerative Disorders. Drug Discovery Approaches for the Treatment of Neurodegenerative Disorders 161 193 .
A. Florence Keller, Jean-Marie C. Bouteiller & Theodore W. Berger. 2017. NMDA Receptors. NMDA Receptors 291 306 .
Kasper B. Hansen, Feng Yi, Riley E. Perszyk, Frank S. Menniti & Stephen F. Traynelis. 2017. NMDA Receptors. NMDA Receptors 1 80 .
Katie L. Strong, Matthew P. Epplin, Yao Jing, Stephen F. Traynelis & Dennis C. Liotta. 2016. Allosterism in Drug Discovery. Allosterism in Drug Discovery 281 309 .
Asya Makhro, Qinghai Tian, Lars Kaestner, Dmitry Kosenkov, Giuseppe Faggian, Max Gassmann, Colin Schwarzwald & Anna Bogdanova. (2016) Cardiac N-methyl d-aspartate Receptors as a Pharmacological Target. Journal of Cardiovascular Pharmacology 68:5, pages 356-373.
Crossref
Nuno Pereira, Francesc Sureda, Maria Pérez, Mercedes Amat & Maria Santos. (2016) Enantiopure Indolo[2,3-a]quinolizidines: Synthesis and Evaluation as NMDA Receptor Antagonists. Molecules 21:8, pages 1027.
Crossref
Ines Lütnant, Dirk Schepmann & Bernhard Wünsch. (2016) Benzimidazolone bioisosteres of potent GluN2B selective NMDA receptor antagonists. European Journal of Medicinal Chemistry 116, pages 136-146.
Crossref
Hiroaki Sakaue, Hiroko Ohide, Masahiro Yamanaka & Ryuichi Konno. 2016. D-Amino Acids. D-Amino Acids 51 64 .
Brooke M. Katzman, Riley E. Perszyk, Hongjie Yuan, Yesim Altas Tahirovic, Ayodeji E. Sotimehin, Stephen F. Traynelis & Dennis C. Liotta. (2015) A novel class of negative allosteric modulators of NMDA receptor function. Bioorganic & Medicinal Chemistry Letters 25:23, pages 5583-5588.
Crossref
Enza Palazzo, Rosaria Romano, Livio Luongo, Serena Boccella, Danilo De Gregorio, Maria Elvira Giordano, Francesca Rossi, Ida Marabese, Maria Antonietta Scafuro, Vito de Novellis & Sabatino Maione. (2015) MMPIP, an mGluR7-selective negative allosteric modulator, alleviates pain and normalizes affective and cognitive behavior in neuropathic mice. Pain 156:6, pages 1060-1073.
Crossref
Masahiro Fujiwara, Mutsushi Kaneko & Miyuki Mizushima. (2015) Ifenprodil for trigeminal neuralgia with resistance to carbamazepine. Palliative Care Research 10:1, pages 501-504.
Crossref
G. Brent Dawe, Mark R. Aurousseau, Bryan A. Daniels & Derek Bowie. (2015) Retour aux sources: defining the structural basis of glutamate receptor activation. The Journal of Physiology 593:1, pages 97-110.
Crossref
Vishal P. Zambre, Varsha A. Hambarde, Nilesh N. Petkar, Chinmay N. Patel & Sanjay D. Sawant. (2015) Structural investigations by in silico modeling for designing NR2B subunit selective NMDA receptor antagonists. RSC Advances 5:30, pages 23922-23940.
Crossref
Narasimhulu Simma, Tanima Bose, Sascha Kahlfuß, Judith Mankiewicz, Theresa Lowinus, Fred Lühder, Thomas Schüler, Burkhart Schraven, Martin Heine & Ursula Bommhardt. (2014) NMDA-receptor antagonists block B-cell function but foster IL-10 production in BCR/CD40-activated B cells. Cell Communication and Signaling 12:1.
Crossref
Digavalli V. Sivarao, Ping Chen, Yili Yang, Yu-Wen Li, Rick Pieschl & Michael K. Ahlijanian. (2014) NR2B Antagonist CP-101,606 Abolishes Pitch-Mediated Deviance Detection in Awake Rats. Frontiers in Psychiatry 5.
Crossref
Nuno A.L. Pereira, Francesc X. Sureda, Roser Esplugas, Maria Pérez, Mercedes Amat & Maria M.M. Santos. (2014) Tryptophanol-derived oxazolopiperidone lactams: Identification of a hit compound as NMDA receptor antagonist. Bioorganic & Medicinal Chemistry Letters 24:15, pages 3333-3336.
Crossref
Y. Zhou & N. C. Danbolt. (2014) Glutamate as a neurotransmitter in the healthy brain. Journal of Neural Transmission 121:8, pages 799-817.
Crossref
Giulia Ambrosi, Silvia Cerri & Fabio Blandini. (2014) A further update on the role of excitotoxicity in the pathogenesis of Parkinson’s disease. Journal of Neural Transmission 121:8, pages 849-859.
Crossref
Jana Sawynok. (2014) Topical and Peripheral Ketamine as an Analgesic. Anesthesia & Analgesia 119:1, pages 170-178.
Crossref
Gisèle Pickering, Bruno Pereira, Véronique Morel, Florence Tiberghien, Elodie Martin, Fabienne Marcaillou, Pascale Picard, Noémie Delage, Géraldine de Montgazon, Marc Sorel, Delphine Roux & Claude Dubray. (2014) Rationale and design of a multicenter randomized clinical trial with memantine and dextromethorphan in ketamine-responder patients. Contemporary Clinical Trials 38:2, pages 314-320.
Crossref
Francesca RossiIda Marabese, Maria De Chiaro, Serena Boccella, Livio Luongo, Francesca Guida, Danilo De Gregorio, Catia Giordano, Vito de Novellis, Enza Palazzo & Sabatino Maione. (2014) Dorsal striatum metabotropic glutamate receptor 8 affects nocifensive responses and rostral ventromedial medulla cell activity in neuropathic pain conditions. Journal of Neurophysiology 111:11, pages 2196-2209.
Crossref
Enza Palazzo, Vito de Novellis, Francesco Rossi & Sabatino Maione. (2014) Supraspinal metabotropic glutamate receptor subtype 8: a switch to turn off pain. Amino Acids.
Crossref
Virginia Andreoli, Elvira Valeria De Marco, Francesca Trecroci, Rita Cittadella, Gemma Di Palma & Antonio Gambardella. (2013) Potential involvement of GRIN2B encoding the NMDA receptor subunit NR2B in the spectrum of Alzheimer’s disease. Journal of Neural Transmission.
Crossref
Willmann Liang, Wai Lam, Hong Tang, Ping Leung & David Yew. (2013) Current Evidence of Chinese Herbal Constituents with Effects on NMDA Receptor Blockade. Pharmaceuticals 6:8, pages 1039-1054.
Crossref
Sylvain Célanire, Benjamin Perry, Robert Lutjens, Sonia Poli & Ian J. Reynolds. 2013. Emerging Drugs and Targets for Parkinson’s Disease. Emerging Drugs and Targets for Parkinson’s Disease 237 265 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.